GENEGUT hosts its third seminar with Prof. Garret FitzGerald on building capacity in translational science
On 18 November, GENEGUT and UCC Futures – Future Medicines hosted the third event in the GENEGUT Seminar Series, featuring an inspiring talk by Prof. Garret FitzGerald, McNeil Professor in Translational Medicine and Therapeutics at the University of Pennsylvania.
GENEGUT: From Lab to Life – Big vs. Small: How Capsule Size Affects Medicine in Pigs
Pigs are widely used to test gastro-resistant oral medicines, but do larger capsules empty reliably? This blog summarises the GENEGUT study comparing capsule sizes 0, 1 and 2, showing all emptied and released their contents, with only minor size effects and no benefit from metoclopramide.
Showcasing GENEGUT Science in 2025: Miguel Ramôa Presents RNA Nanoparticle Research Across Europe
Throughout 2025, Miguel Ramôa from University College Cork (UCC) represented GENEGUT at several national and international scientific events, sharing progress on the development of polymeric nanoparticles for the intestinal delivery of RNA as a novel treatment approach for ileal Crohn’s disease.
Tamas Sohajda from CarboHyde presents “Small Ring – Big Impact” at the 8th European Cyclodextrin Conference
From 9–12 September 2025, Tamas Sohajda from CarboHyde took the stage at the 8th European Cyclodextrin Conference in Milan, a leading forum that gathered around 180 experts from academia and industry working on cyclodextrins and their wide-ranging applications. Although European in focus, the event attracts a global community of researchers and innovators.
GENEGUT presented by i3S partner Prof. Bruno Sarmento at the CRS Annual Meeting 2025
On 17 July 2025, Prof. Bruno Sarmento from the Institute for Research and Innovation in Health (i3S), Porto, presented GENEGUT’s latest advances at the Controlled Release Society (CRS) Annual Meeting in Philadelphia, USA.
Dr Madlen Hubert showcases 3D intestinal organoid research in Sweden
In early 2025, Dr Madlen Hubert, an Associate Professor at Uppsala University, presented her GENEGUT-related research at two distinguished events in Sweden, sharing innovative work on the application of 3D human intestinal organoids in drug delivery science.